{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-021726","form_type":"8-K","ticker":"LFMD","cik":"0000948320","company_name":"LifeMD, Inc.","filed_at":"2023-06-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.967236+00:00","generated_at":"2026-06-13T22:13:34.112982+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"LifeMD grants GC Eric Yecies 375,000 restricted shares with performance milestones","bullets":["375,000 restricted shares granted; replaces 200,000 stock options ($7.55 strike) and 105,000 performance units cancelled.","150,000 shares time-vest: 12,500 immediately, 37,500 Nov 20, 2023, 100,000 Jan 1, 2024.","225,000 performance shares: $100M net revenue/5% EBITDA margin by 2025; $150M/10% by 2026; $200M/10% by 2027.","75,000 shares vest by CEO/Board discretion for 2023 and 2024 performance on 3/1/24 and 3/1/25.","Unvested shares accelerate upon change of control or termination without cause/good reason."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-021726","json":"https://secwatch.observer/filing/0001493152-23-021726.json","markdown":"https://secwatch.observer/filing/0001493152-23-021726.md","text":"https://secwatch.observer/filing/0001493152-23-021726.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/948320/000149315223021726/0001493152-23-021726-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/948320/000149315223021726/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T22:13:34.112982+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}